| Dr Samuel Dean Bailey, MD | |
|
200 Medical Center Dr, Hazard, KY 41701-9466 | |
| (606) 487-7902 | |
| Not Available |
| Full Name | Dr Samuel Dean Bailey |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 200 Medical Center Dr, Hazard, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114180080 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 42778 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hazard Arh Regional Medical Center | Hazard, KY | Hospital |
| Highlands Arh Regional Medical Center | Prestonsburg, KY | Hospital |
| Whitesburg Arh Hospital | Whitesburg, KY | Hospital |
| Baptist Health Corbin | Corbin, KY | Hospital |
| Pikeville Medical Center | Pikeville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Appalachian Regional Healthcare Inc. | 0840107835 | 232 |
| Arh Tug Valley Health Services, Inc. | 4183953805 | 65 |
News Archive
AmeriCares this week pledged to expand its medical assistance across the United States at the 2009 Clinton Global Initiative in New York City. AmeriCares U.S. Medical Assistance Program, announced by President & CEO Curt Welling, is a two-year commitment to improve community health by donating medicines and medical supplies to health care organizations serving the uninsured and underinsured throughout the country.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
In the first scientific publication from The Genographic Project, a five-year effort to understand the human journey, we see the first attempts to answer these age-old questions.
CTI BioPharma Corp. and Baxter International's Bioscience business today announced data from PERSIST-1 – a randomized Phase 3 registration-directed trial examining pacritinib for the treatment of myelofibrosis – in a late-breaking oral session at the 51st Annual Meeting of the American Society of Clinical Oncology, May 29-June 2, 2015 in Chicago, Ill.
› Verified 9 days ago
| Entity Name | Appalachian Regional Healthcare Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528148012 PECOS PAC ID: 0840107835 Enrollment ID: O20031125000520 |
News Archive
AmeriCares this week pledged to expand its medical assistance across the United States at the 2009 Clinton Global Initiative in New York City. AmeriCares U.S. Medical Assistance Program, announced by President & CEO Curt Welling, is a two-year commitment to improve community health by donating medicines and medical supplies to health care organizations serving the uninsured and underinsured throughout the country.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
In the first scientific publication from The Genographic Project, a five-year effort to understand the human journey, we see the first attempts to answer these age-old questions.
CTI BioPharma Corp. and Baxter International's Bioscience business today announced data from PERSIST-1 – a randomized Phase 3 registration-directed trial examining pacritinib for the treatment of myelofibrosis – in a late-breaking oral session at the 51st Annual Meeting of the American Society of Clinical Oncology, May 29-June 2, 2015 in Chicago, Ill.
› Verified 9 days ago
| Entity Name | Southeastern Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20090715000150 |
News Archive
AmeriCares this week pledged to expand its medical assistance across the United States at the 2009 Clinton Global Initiative in New York City. AmeriCares U.S. Medical Assistance Program, announced by President & CEO Curt Welling, is a two-year commitment to improve community health by donating medicines and medical supplies to health care organizations serving the uninsured and underinsured throughout the country.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
In the first scientific publication from The Genographic Project, a five-year effort to understand the human journey, we see the first attempts to answer these age-old questions.
CTI BioPharma Corp. and Baxter International's Bioscience business today announced data from PERSIST-1 – a randomized Phase 3 registration-directed trial examining pacritinib for the treatment of myelofibrosis – in a late-breaking oral session at the 51st Annual Meeting of the American Society of Clinical Oncology, May 29-June 2, 2015 in Chicago, Ill.
› Verified 9 days ago
| Entity Name | Arh Tug Valley Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639949696 PECOS PAC ID: 4183953805 Enrollment ID: O20190905002344 |
News Archive
AmeriCares this week pledged to expand its medical assistance across the United States at the 2009 Clinton Global Initiative in New York City. AmeriCares U.S. Medical Assistance Program, announced by President & CEO Curt Welling, is a two-year commitment to improve community health by donating medicines and medical supplies to health care organizations serving the uninsured and underinsured throughout the country.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
In the first scientific publication from The Genographic Project, a five-year effort to understand the human journey, we see the first attempts to answer these age-old questions.
CTI BioPharma Corp. and Baxter International's Bioscience business today announced data from PERSIST-1 – a randomized Phase 3 registration-directed trial examining pacritinib for the treatment of myelofibrosis – in a late-breaking oral session at the 51st Annual Meeting of the American Society of Clinical Oncology, May 29-June 2, 2015 in Chicago, Ill.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel Dean Bailey, MD 100 Airport Gardens Rd, Hazard, KY 41701-9529 Ph: (606) 487-7503 | Dr Samuel Dean Bailey, MD 200 Medical Center Dr, Hazard, KY 41701-9466 Ph: (606) 487-7902 |
News Archive
AmeriCares this week pledged to expand its medical assistance across the United States at the 2009 Clinton Global Initiative in New York City. AmeriCares U.S. Medical Assistance Program, announced by President & CEO Curt Welling, is a two-year commitment to improve community health by donating medicines and medical supplies to health care organizations serving the uninsured and underinsured throughout the country.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
In the first scientific publication from The Genographic Project, a five-year effort to understand the human journey, we see the first attempts to answer these age-old questions.
CTI BioPharma Corp. and Baxter International's Bioscience business today announced data from PERSIST-1 – a randomized Phase 3 registration-directed trial examining pacritinib for the treatment of myelofibrosis – in a late-breaking oral session at the 51st Annual Meeting of the American Society of Clinical Oncology, May 29-June 2, 2015 in Chicago, Ill.
› Verified 9 days ago
Dr. Raymond Elsoueidi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 | |
Dr. Gregory Balabanian, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Center Dr, Hazard, KY 41701 Phone: 606-487-7510 Fax: 606-439-6793 | |
Dr. Thomas E. Karelis Jr., MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 311 Roy Campbell Dr, Hazard, KY 41701 Phone: 606-487-0776 Fax: 606-487-0777 | |
Vidya B Yalamanchi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Center Dr, Hazard, KY 41701 Phone: 606-487-7510 Fax: 606-439-6793 | |
Dr. Jeffery Prater, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 271 E Main St, Hazard, KY 41701 Phone: 606-439-1316 Fax: 606-439-3922 | |
Mr. Ionut Stefanescu Sturz, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 311 Roy Campbell Drive, Hazard, KY 41701 Phone: 606-487-0776 Fax: 606-487-0777 |